{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:45:34Z","timestamp":1790390734867,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173426"],"award-info":[{"award-number":["82173426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["Natural Science Foundation of Hunan Province"],"award-info":[{"award-number":["Natural Science Foundation of Hunan Province"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03905-9","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T11:26:49Z","timestamp":1739532409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dihydromyricetin alleviates imiquimod-induced psoriasiform inflammation by inhibiting M1 macrophage polarization"],"prefix":"10.1007","volume":"317","author":[{"given":"Rao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"9997","key":"3905_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP (2015) Psoriasis. Lancet 386(9997):983\u2013994","journal-title":"Lancet"},{"key":"3905_CR2","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY (2016) Gottlieb AB: Psoriasis. Nat Rev Dis Primers 2:16082","journal-title":"Nat Rev Dis Primers"},{"issue":"10281","key":"3905_CR3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J (2021) Psoriasis. Lancet 397(10281):1301\u20131315","journal-title":"Lancet"},{"issue":"19","key":"3905_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323(19):1945\u20131960","journal-title":"JAMA"},{"key":"3905_CR5","doi-asserted-by":"publisher","first-page":"102916","DOI":"10.1016\/j.jaut.2022.102916","volume":"133","author":"J Yu","year":"2022","unstructured":"Yu J, Zhao Q, Wang X, Zhou H, Hu J, Gu L, Hu Y, Zeng F, Zhao F, Yue C et al (2022) Pathogenesis, multi-omics research, and clinical treatment of psoriasis. J Autoimmun 133:102916","journal-title":"J Autoimmun"},{"issue":"1","key":"3905_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","volume":"38","author":"SK Mahil","year":"2016","unstructured":"Mahil SK, Capon F, Barker JN (2016) Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol 38(1):11\u201327","journal-title":"Semin Immunopathol"},{"issue":"10275","key":"3905_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C, Sabat R (2021) Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397(10275):754\u2013766","journal-title":"Lancet"},{"key":"3905_CR8","doi-asserted-by":"publisher","first-page":"686360","DOI":"10.3389\/fphar.2021.686360","volume":"12","author":"X Tang","year":"2021","unstructured":"Tang X, Liu Z, Yang Z, Xu S, Wang M, Chen X, Wen Z, Huang R (2021) The effect of Chinese Medicine Compound in the treatment of rheumatoid arthritis on the level of rheumatoid factor and anti-cyclic citrullinated peptide antibodies: a systematic review and Meta-analysis. Front Pharmacol 12:686360","journal-title":"Front Pharmacol"},{"key":"3905_CR9","doi-asserted-by":"publisher","first-page":"155041","DOI":"10.1016\/j.phymed.2023.155041","volume":"120","author":"H Chen","year":"2023","unstructured":"Chen H, Su Z, Pan X, Zheng X, Li H, Ye Z, Tang B, Lu Y, Zheng G, Lu C (2023) Phytochemicals: targeting autophagy to treat psoriasis. Phytomedicine 120:155041","journal-title":"Phytomedicine"},{"key":"3905_CR10","doi-asserted-by":"crossref","unstructured":"Wei C, Chen X, Chen D, Yu B, Zheng P, He J, Chen H, Yan H, Luo Y, Huang Z (2022) Dihydromyricetin enhances intestinal antioxidant capacity of growing-finishing pigs by activating ERK\/Nrf2\/HO-1 signaling pathway. Antioxid (Basel) 11(4)","DOI":"10.3390\/antiox11040704"},{"key":"3905_CR11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3389\/fphar.2018.01204","volume":"9","author":"J Zhang","year":"2018","unstructured":"Zhang J, Chen Y, Luo H, Sun L, Xu M, Yu J, Zhou Q, Meng G, Yang S (2018) Recent update on the pharmacological effects and mechanisms of Dihydromyricetin. Front Pharmacol 9:1204","journal-title":"Front Pharmacol"},{"key":"3905_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.tifs.2019.07.038","volume":"91","author":"D Liu","year":"2019","unstructured":"Liu D, Mao Y, Ding L, Zeng XA (2019) Dihydromyricetin: a review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability. Trends Food Sci Technol 91:586\u2013597","journal-title":"Trends Food Sci Technol"},{"key":"3905_CR13","doi-asserted-by":"crossref","unstructured":"Chen Y, Zheng Y, Chen R, Shen J, Zhang S, Gu Y, Shi J, Meng G (2023) Dihydromyricetin attenuates Diabetic Cardiomyopathy by inhibiting oxidative stress, inflammation and necroptosis via Sirtuin 3 activation. Antioxid (Basel) 12(1)","DOI":"10.3390\/antiox12010200"},{"key":"3905_CR14","doi-asserted-by":"publisher","first-page":"1201007","DOI":"10.3389\/fnut.2023.1201007","volume":"10","author":"I Janilkarn-Urena","year":"2023","unstructured":"Janilkarn-Urena I, Idrissova A, Zhang M, VanDreal M, Sanghavi N, Skinner SG, Cheng S, Zhang Z, Watanabe J, Asatryan L et al (2023) Dihydromyricetin supplementation improves ethanol-induced lipid accumulation and inflammation. Front Nutr 10:1201007","journal-title":"Front Nutr"},{"issue":"1","key":"3905_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12944-024-02263-1","volume":"23","author":"Q Hu","year":"2024","unstructured":"Hu Q, Li C, Zhang T, Yi L, Shan Y, Ma X, Cai T, Ran L, Shen H, Li Y (2024) Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy. Lipids Health Dis 23(1):279","journal-title":"Lipids Health Dis"},{"issue":"6","key":"3905_CR16","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/sca.21339","volume":"38","author":"R Wang","year":"2016","unstructured":"Wang R, Pi J, Su X, Liu J, Zeng X, Wong I, Huang L, Zhou H, Cai J, Li T et al (2016) Dihydromyricetin suppresses inflammatory responses in vitro and in vivo through inhibition of IKK\u03b2 activity in macrophages. Scanning 38(6):901\u2013912","journal-title":"Scanning"},{"issue":"7","key":"3905_CR17","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1021\/acs.jnatprod.5b00275","volume":"78","author":"XL Hou","year":"2015","unstructured":"Hou XL, Tong Q, Wang WQ, Shi CY, Xiong W, Chen J, Liu X, Fang JG (2015) Suppression of inflammatory responses by Dihydromyricetin, a Flavonoid from Ampelopsis Grossedentata, via inhibiting the activation of NF-\u03baB and MAPK signaling pathways. J Nat Prod 78(7):1689\u20131696","journal-title":"J Nat Prod"},{"issue":"1","key":"3905_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12951-021-00847-y","volume":"19","author":"M Zhang","year":"2021","unstructured":"Zhang M, Cheng J, Hu J, Luo J, Zhang Y, Lu F, Kong H, Qu H, Zhao Y (2021) Green Phellodendri Chinensis Cortex-based carbon dots for ameliorating imiquimod-induced psoriasis-like inflammation in mice. J Nanobiotechnol 19(1):105","journal-title":"J Nanobiotechnol"},{"key":"3905_CR19","doi-asserted-by":"publisher","first-page":"117231","DOI":"10.1016\/j.lfs.2019.117231","volume":"243","author":"L Li","year":"2020","unstructured":"Li L, Zhang HY, Zhong XQ, Lu Y, Wei J, Li L, Chen H, Lu C, Han L (2020) PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization. Life Sci 243:117231","journal-title":"Life Sci"},{"issue":"3","key":"3905_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.det.2024.02.006","volume":"42","author":"JE Hawkes","year":"2024","unstructured":"Hawkes JE, Al-Saedy M, Bouch\u00e9 N, Al-Saedy S, Drew DT, Song EJ (2024) The Psoriasis Treatment Pipeline: an overview and update. Dermatol Clin 42(3):365\u2013375","journal-title":"Dermatol Clin"},{"issue":"4","key":"3905_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00403-022-02410-7","volume":"315","author":"SJ Eley","year":"2023","unstructured":"Eley SJ, DeMeo DP, Korman NJ, Carroll BT (2023) Equity in the usage of biologics for psoriasis in the working poor. Arch Dermatol Res 315(4):1029\u20131031","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"3905_CR22","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00403-013-1372-3","volume":"305","author":"A Nast","year":"2013","unstructured":"Nast A, Mrowietz U, Kragballe K, de Jong EM, Puig L, Reich K, Warren RB, Werner R, Kopkow C, Schmitt J (2013) Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis\u2013a multinational cross-sectional study. Arch Dermatol Res 305(10):899\u2013907","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"3905_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/17425255.2024.2337749","volume":"20","author":"A Lo","year":"2024","unstructured":"Lo A, Greenzaid JD, Gantz HY, Chodri K, Feldman SR (2024) Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients. Expert Opin Drug Metab Toxicol 20(4):235\u2013248","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"8","key":"3905_CR24","first-page":"1126","volume":"22","author":"LK Trefzer","year":"2024","unstructured":"Trefzer LK, Pilz AC, Eyerich K (2024) Dermatologic adverse events caused by biologic treatments - Pathogenesis and management. J Dtsch Dermatol Ges 22(8):1126\u20131136","journal-title":"J Dtsch Dermatol Ges"},{"key":"3905_CR25","doi-asserted-by":"crossref","unstructured":"Huang TH, Lin CF, Alalaiwe A, Yang SC, Fang JY (2019) Apoptotic or antiproliferative activity of Natural products against keratinocytes for the Treatment of Psoriasis. Int J Mol Sci 20(10)","DOI":"10.3390\/ijms20102558"},{"key":"3905_CR26","doi-asserted-by":"crossref","unstructured":"Lee YG, Jung Y, Choi HK, Lee JI, Lim TG, Lee J (2024) Natural product-derived compounds Targeting keratinocytes and Molecular pathways in Psoriasis therapeutics. Int J Mol Sci 25(11)","DOI":"10.3390\/ijms25116068"},{"key":"3905_CR27","doi-asserted-by":"publisher","first-page":"116788","DOI":"10.1016\/j.jep.2023.116788","volume":"317","author":"T Zeng","year":"2023","unstructured":"Zeng T, Song Y, Qi S, Zhang R, Xu L, Xiao P (2023) A comprehensive review of vine tea: origin, research on Materia Medica, phytochemistry and pharmacology. J Ethnopharmacol 317:116788","journal-title":"J Ethnopharmacol"},{"key":"3905_CR28","doi-asserted-by":"crossref","unstructured":"Xie K, He X, Chen K, Chen J, Sakao K, Hou DX (2019) Antioxidant properties of a traditional vine tea, Ampelopsis grossedentata. Antioxid (Basel) 8(8)","DOI":"10.3390\/antiox8080295"},{"issue":"4","key":"3905_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/hed.10218","volume":"25","author":"M Liu","year":"2003","unstructured":"Liu M, Lawson G, Delos M, Jamart J, Ide C, Coche E, Weynand B, Desuter G, Hamoir M, Remacle M et al (2003) Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations. Head Neck 25(4):280\u2013288","journal-title":"Head Neck"},{"issue":"6","key":"3905_CR30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1124\/mol.112.077735","volume":"81","author":"Z Tan","year":"2012","unstructured":"Tan Z, Wortman M, Dillehay KL, Seibel WL, Evelyn CR, Smith SJ, Malkas LH, Zheng Y, Lu S, Dong Z (2012) Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth. Mol Pharmacol 81(6):811\u2013819","journal-title":"Mol Pharmacol"},{"issue":"5","key":"3905_CR31","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/bph.15983","volume":"180","author":"L Zhang","year":"2023","unstructured":"Zhang L, Ma X, Shi R, Zhang L, Zhao R, Duan R, Qin Y, Gao S, Li X, Duan J et al (2023) Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A. Br J Pharmacol 180(5):628\u2013646","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3905_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13578-024-01238-0","volume":"14","author":"J Lee","year":"2024","unstructured":"Lee J, Kim MY, Kim HJ, Choi WS, Kim HS (2024) Impaired autophagy in myeloid cells aggravates psoriasis-like skin inflammation through the IL-1\u03b2\/CXCL2\/neutrophil axis. Cell Biosci 14(1):57","journal-title":"Cell Biosci"},{"key":"3905_CR33","doi-asserted-by":"crossref","unstructured":"Yoshida M, Funasaka Y, Saeki H, Yamamoto M, Kanda N (2023) Dietary Fiber inulin improves murine Imiquimod-Induced Psoriasis-like Dermatitis. Int J Mol Sci 24(18)","DOI":"10.3390\/ijms241814197"},{"issue":"4","key":"3905_CR34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/cmi.2012.15","volume":"9","author":"Y Cai","year":"2012","unstructured":"Cai Y, Fleming C, Yan J (2012) New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol 9(4):302\u2013309","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"3905_CR35","doi-asserted-by":"publisher","first-page":"e0290637","DOI":"10.1371\/journal.pone.0290637","volume":"18","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang Q, Sun S, Jiang L (2023) The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice. PLoS ONE 18(8):e0290637","journal-title":"PLoS ONE"},{"key":"3905_CR36","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.2147\/JIR.S379349","volume":"15","author":"S Jin","year":"2022","unstructured":"Jin S, Wang Y, Qie C, Yang L, Wu Y, Zhang T, Di J, Liu J (2022) Single-cell RNA sequencing reveals the Immune Cell Profiling in IMQ Induced Psoriasis-Like Model. J Inflamm Res 15:5999\u20136012","journal-title":"J Inflamm Res"},{"key":"3905_CR37","doi-asserted-by":"publisher","first-page":"114469","DOI":"10.1016\/j.biopha.2023.114469","volume":"161","author":"Q Sun","year":"2023","unstructured":"Sun Q, Hu S, Lou Z, Gao J (2023) The macrophage polarization in inflammatory dermatosis and its potential drug candidates. Biomed Pharmacother 161:114469","journal-title":"Biomed Pharmacother"},{"key":"3905_CR38","doi-asserted-by":"publisher","first-page":"102645","DOI":"10.1016\/j.ebiom.2020.102645","volume":"52","author":"A Achek","year":"2020","unstructured":"Achek A, Kwon HK, Patra MC, Shah M, Hong R, Lee WH, Baek WY, Choi YS, Kim GY, Pham TLH et al (2020) A peptide derived from the core \u03b2-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models. EBioMedicine 52:102645","journal-title":"EBioMedicine"},{"issue":"1","key":"3905_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12934-023-02171-6","volume":"22","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhu D, Zhang Y, Xia F, Zhu J, Dai J, Zhuge X (2023) Extracellular vesicles produced by avian pathogenic Escherichia coli (APEC) activate macrophage proinflammatory response and neutrophil extracellular trap (NET) formation through TLR4 signaling. Microb Cell Fact 22(1):177","journal-title":"Microb Cell Fact"},{"key":"3905_CR40","doi-asserted-by":"crossref","unstructured":"Chen S, Chen L, Ye L, Jiang Y, Li Q, Zhang H, Zhang R, Li H, Yu D, Zhang R et al (2022) PP2A-mTOR-p70S6K\/4E-BP1 axis regulates M1 polarization of pulmonary macrophages and promotes ambient particulate matter induced mouse lung injury. J Hazard Mater 424(Pt C):127624.","DOI":"10.1016\/j.jhazmat.2021.127624"},{"issue":"Pt 2","key":"3905_CR41","doi-asserted-by":"publisher","first-page":"127700","DOI":"10.1016\/j.ijbiomac.2023.127700","volume":"254","author":"F Zeng","year":"2024","unstructured":"Zeng F, Li Y, Zhang X, Shen L, Zhao X, Beta T, Li B, Chen R, Huang W (2024) Immune regulation and inflammation inhibition of Arctium lappa L. polysaccharides by TLR4\/NF-\u03baB signaling pathway in cells. Int J Biol Macromol 254(Pt 2):127700","journal-title":"Int J Biol Macromol"},{"key":"3905_CR42","doi-asserted-by":"publisher","first-page":"115195","DOI":"10.1016\/j.carbpol.2019.115195","volume":"224","author":"KK Asanka Sanjeewa","year":"2019","unstructured":"Asanka Sanjeewa KK, Jayawardena TU, Kim HS, Kim SY, Shanura Fernando IP, Wang L, Abetunga DTU, Kim WS, Lee DS, Jeon YJ (2019) Fucoidan isolated from Padina commersonii inhibit LPS-induced inflammation in macrophages blocking TLR\/NF-\u03baB signal pathway. Carbohydr Polym 224:115195","journal-title":"Carbohydr Polym"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03905-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T22:54:33Z","timestamp":1739573673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03905-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3905"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03905-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Central South University\u2019s ethical committee approved this study\u2019s sampling, procedures, and treatments (Ethical code: CSU-2022-0376).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}